Want to see KR:001360 full AI Analyst Report?
SAMSUNG PHARMACEUTICAL.CO.,Ltd. (001360) Financial Statements
SAMSUNG PHARMACEUTICAL.CO.,Ltd. Financial Overview
SAMSUNG PHARMACEUTICAL.CO.,Ltd.'s market cap is currently $113.23B. The company's EPS TTM is $-1451.04; its P/E ratio is -0.83; SAMSUNG PHARMACEUTICAL.CO.,Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 46.07B | $ 44.29B | $ 51.96B | $ 51.83B | $ 54.90B |
| Gross Profit | $ 14.64B | $ 19.77B | $ 22.97B | $ 24.62B | $ 9.28B |
| Operating Income | $ -19.46B | $ -14.83B | $ -18.04B | $ -13.96B | $ -19.14B |
| EBITDA | $ -18.06B | $ -11.74B | $ -21.69B | $ -21.97B | $ -36.46B |
| Net Income | $ 11.55B | $ -14.09B | $ -24.81B | $ -25.09B | $ -40.28B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 16.17B | $ 10.39B | $ 4.28B | $ 55.99B | $ 64.40B |
| Total Assets | $ 167.44B | $ 128.45B | $ 93.48B | $ 117.91B | $ 145.46B |
| Total Debt | $ 17.70B | $ 5.16B | $ 595.49M | $ 2.00B | $ 2.12B |
| Net Debt | $ 6.53B | $ -2.23B | $ -3.69B | $ -33.99B | $ -23.98B |
| Total Liabilities | $ 46.39B | $ 22.60B | $ 15.89B | $ 15.32B | $ 18.19B |
| Stockholders' Equity | $ 121.04B | $ 105.86B | $ 77.58B | $ 102.59B | $ 127.27B |
| Cash Flow | |||||
| Free Cash Flow | $ -10.10B | $ -17.68B | $ -40.44B | $ -4.95B | $ -11.23B |
| Operating Cash Flow | $ -10.05B | $ -17.30B | $ -27.66B | $ -1.91B | $ -7.16B |
| Investing Cash Flow | $ -12.19B | $ -22.34B | $ -2.64B | $ 12.82B | $ 18.99B |
| Financing Cash Flow | $ 26.02B | $ 42.72B | $ -1.42B | $ -1.00B | $ -12.21B |
Currency in KRW